ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹5,527 Cr | ₹7,827 Cr | ₹7,861 Cr | ₹8,269 Cr | ₹7,343 Cr |
What is the latest Total Current Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹5,527 Cr |
Mar2022 | ₹7,827 Cr |
Mar2021 | ₹7,861 Cr |
Mar2020 | ₹8,269 Cr |
Mar2019 | ₹7,343 Cr |
How is Total Current Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹5,527 Cr | -29.39 | |
Mar2022 | ₹7,827 Cr | -0.44 | |
Mar2021 | ₹7,861 Cr | -4.94 | |
Mar2020 | ₹8,269 Cr | 12.62 | |
Mar2019 | ₹7,343 Cr | - |
Compare Total Current Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹100,690.4 Cr | -5.5% | 1.3% | 99.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹350,339.0 Cr | -0.5% | -3.8% | 50.8% | Stock Analytics | |
CIPLA | ₹116,930.0 Cr | -2% | 2% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹114,416.0 Cr | 1.3% | 8.7% | 26.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,546.9 Cr | -1.7% | -8% | 28.9% | Stock Analytics | |
MANKIND PHARMA | ₹85,978.3 Cr | 1.5% | -8.1% | 53.1% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -5.5% |
1.3% |
99.9% |
SENSEX | -1.9% |
-0.7% |
18.3% |
You may also like the below Video Courses